These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 308223)

  • 1. New treatment for patients with iron overload.
    Griffith P; Burks J
    J Nurs Care; 1978 Sep; 11(9):12-4. PubMed ID: 308223
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of treatment with long-term chelating agents on iron overload in thalassaemia.
    Letsky EA; Flynn DM; Barry M
    Br J Haematol; 1973 Aug; 25(2):285. PubMed ID: 4726921
    [No Abstract]   [Full Text] [Related]  

  • 3. The development of new drugs for use in iron chelation therapy.
    Grady RW
    Birth Defects Orig Artic Ser; 1976; 12(8):161-75. PubMed ID: 795480
    [No Abstract]   [Full Text] [Related]  

  • 4. Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid.
    Peterson CM; Graziano JH; Grady RW; Jones RL; Markenson A; Lavi U; Canale V; Gray GF; Cerami A; Miller DR
    Exp Hematol; 1979 Feb; 7(2):74-80. PubMed ID: 371974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalassemia in Italy: treatment of Cooley disease and iron kinetics in heterozygotes.
    Rotoli B
    Birth Defects Orig Artic Ser; 1976; 12(8):53-61. PubMed ID: 1009235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of iron overload in Cooley's anemia.
    Cohen A; Mizanin J; Schwartz E
    Ann N Y Acad Sci; 1985; 445():274-81. PubMed ID: 3860130
    [No Abstract]   [Full Text] [Related]  

  • 7. Thalassemia.
    Brown EB
    Prog Clin Biol Res; 1983; 127():33-42. PubMed ID: 6889403
    [No Abstract]   [Full Text] [Related]  

  • 8. Spleen iron content is low in thalassemia.
    Borgna-Pignatti C; De Stefano P; Bongo IG; Avato F; Cazzola M
    Am J Pediatr Hematol Oncol; 1984; 6(3):340-3. PubMed ID: 6517228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
    Pippard MJ; Weatherall DJ
    Haematologia (Budap); 1984; 17(1):17-24. PubMed ID: 6724353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic iron overload: new chelators and new strategies.
    Fairbanks VF
    J Lab Clin Med; 1978 Aug; 92(2):141-3. PubMed ID: 681806
    [No Abstract]   [Full Text] [Related]  

  • 11. Iron excretion in thalassemia after the administration of chelating agents.
    Markum AH; Iskandar W; Keng KL; Odang O
    Paediatr Indones; 1969; 9(3):89-98. PubMed ID: 4981722
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose tolerance and chelation therapy in patients with thalassaemia major.
    Capra L; Atti G; De Sanctis V; Candini G
    Haematologica; 1983; 68(1):63-8. PubMed ID: 6404709
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of thalassemia in Los Angeles.
    Hyman CB; Ortega JA; Costin G; Landing B; Lazerson J; Leimbrock S; Lurie P
    Birth Defects Orig Artic Ser; 1976; 12(8):43-52. PubMed ID: 1009234
    [No Abstract]   [Full Text] [Related]  

  • 14. Thalassemia in Britain and Australia.
    Modell B; Matthews R
    Birth Defects Orig Artic Ser; 1976; 12(8):13-29. PubMed ID: 795477
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.
    Nienhuis AW; Delea C; Aamodt R; Bartter F; Anderson WF
    Birth Defects Orig Artic Ser; 1976; 12(8):177-85. PubMed ID: 795481
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron overload: pathogenesis and treatment with chelating agents.
    Huebers H
    Blut; 1983 Aug; 47(2):61-7. PubMed ID: 6871476
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential usefulness of free radical scavengers in iron overload.
    Graziano JH
    Birth Defects Orig Artic Ser; 1976; 12(8):135-43. PubMed ID: 795478
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled trial of long-term chelation therapy in homozygous beta-thalassemia.
    Letsky EA
    Birth Defects Orig Artic Ser; 1976; 12(8):31-41. PubMed ID: 1009233
    [No Abstract]   [Full Text] [Related]  

  • 19. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ; Kartikasari AE; Georgiou NA
    Hemoglobin; 2008; 32(1-2):123-34. PubMed ID: 18274990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ascorbic acid status in thalassemia major.
    Tagliabue A; Turconi G; Allegrini M; De Stefano P; Borgna-Pignatti C; Bongo I; Dezza L; Cazzola M
    Haematologica; 1984; 69(5):542-8. PubMed ID: 6437931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.